Document is current
Any future updates will be listed below
-
Authors
Baillie, J. Kenneth https://orcid.org/0000-0001-5258-793X
Angus, Derek
Burnham, Katie
Calandra, Thierry
Calfee, Carolyn
Gutteridge, Alex
Hacohen, Nir
Khatri, Purvesh
Langley, Raymond
Ma’ayan, Avi
Marshall, John
Maslove, David
Prescott, Hallie C.
Rowan, Kathy
Scicluna, Brendon P.
Seymour, Christopher
Shankar-Hari, Manu
Shapiro, Nathan
Joost Wiersinga, W.
Singer, Mervyn
Randolph, Adrienne G.
-
Funding
Funding for this research was provided by:
International Sepsis Forum
- License Information
-
More Information
Article History
Received: 8 June 2024
Accepted: 16 September 2024
First Online: 21 October 2024
Conflicts of interest
: The International Sepsis Forum has been generously sponsored by Cytosorbents, Genentech, GE, BD, deepull, Gentian, Inflammatix, Oxford Nanopore Technologies, Sanofi, and Baxter. JKB reports research funding from Wellcome, MRC, BBSRC, UKRI, Baillie Gifford, and NIHR. JM reports grants from the Canadian Institutes of Health Research and has served as chair of data and safety monitoring boards for AM Pharma and Adrenomed. MS-H reports funding from NIHR. TvdP has received grants from the EU's Horizon 2020 research and innovation funding programme. All other authors declare no competing interests. AG is a shareholder of and has received salaries from GSK and Novo Nordisk. AGR is the Chair of the International Sepsis Forum and has received consultancy fees from Inotrem, Thermo Fisher and Volition, and receives funding from the US National Institute of Allergy and Infectious Diseases and Centers for Disease Control. TC reports grants from the Swiss Academy of Medical Sciences, the Swiss Federal Institute of Technology Zurich and the EU's Horizon 2020 research and innovation funding programme, and consulting, speaker’s bureau, data safety monitoring boards from Basilea, Cidara, Gilead Sciences, MSD Merck Sharp & Dohme, Moderna, Novartis, Pfizer, Shionogi (payments made to his institution.) CSC reports grant funding from the NIH, Roche-Genentech, and Quantum Leap Healthcare Collaborative, and has served as a consultant or advisor to Vasomune, Gen1e Life Scienes, Arrowhead, Cellenkos, Calcimedica, EnliTISA, Novaris, Aerogen, Fisher-Paykel, and Boehringer. BPS received funds from the European Society of Intensive Care Medicine (ESICM) and Xjenza Malta Research Excellence Program (REP-2023-049). CWS reports grants from the US National Institutes of Health National Institute of General Medical Sciences, during the conduct of the study, and personal fees from Inotrem and Beckman Coulter, outside of the submitted work.
